Dentoalveolar surgical procedures safe in patients with IBD or GERD

They analyzed the complication rates and outcomes in patients with gastrointestinal disorders who had undergone maxillofacial surgery.

They retrospectively analyzed 289 patients with inflammatory bowel disease (IBD), 142 with gastroesophageal reflux disease (GERD), and 42 with celiac disease (452 total) who had undergone oral and/or maxillofacial surgery. We examined their characteristics, medications they had taken, surgeries they had undergone, and complications they had experienced. Based on the results of univariate analysis, we selected variables for multivariable logistic regression to identify independent predictors of postoperative complications.

Results

They found a complication rate of 10% in patients with IBD, 6.9% in patients with GERD, and 9.5% in patients with celiac disease. Dentoalveolar treatment was significantly associated with an increased risk of postoperative complications in patients with IBD and GERD.

Oral and/or maxillofacial surgery is safe in most patients with IBD, GERD, and celiac disease. Preventive measures for postoperative complications should be considered in patients with IBD and GERD undergoing dentoalveolar treatment.

Reference:

The impact of gastrointestinal diseases on oral and maxillofacial surgery outcomes

Charlotte Lens, Jonas Ver Berne, Constantinus Politis. Published:May 13, 2023DOI:https://doi.org/10.1016/j.oooo.2023.05.004

Keywords:

Dentoalveolar, surgical, procedures, safe, patients, IBD, GERD, Charlotte Lens, Jonas Ver Berne, Constantinus Politis, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology